Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) Peptide
LILRB1
Reactivity: Human, Mouse, Rat
Host: Synthetic
BP
-
- Target See all LILRB1 products
- LILRB1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
- Origin
- Human, Mouse, Rat
- Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-CD85j Antibody reactivity.
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- LILRB1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
- Synonyms
- CD85J Peptide, ILT-2 Peptide, ILT2 Peptide, LIR-1 Peptide, LIR1 Peptide, MIR-7 Peptide, MIR7 Peptide, leukocyte immunoglobulin like receptor B1 Peptide, LILRB1 Peptide
- Background
- ILT2, LIR1, MIR7, Leukocyte immunoglobulin-like receptor subfamily B member 1, LIR-1, Leukocyte immunoglobulin-like receptor 1, CD85 antigen-like family member J, Immunoglobulin-like transcript 2, ILT-2, Monocyte/macrophage immunoglobulin-like receptor 7, MIR-7, CD85j
- Gene ID
- 10859
- UniProt
- Q8NHL6
-
You are here:
